Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.canlet.2010.10.025
Title: Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Authors: Kannaiyan, R.
Shanmugam, M.K. 
Sethi, G.
Keywords: Angiogenesis
Cancer
Celastrol
Inflammatory disorders
Metastasis
Issue Date: 1-Apr-2011
Citation: Kannaiyan, R., Shanmugam, M.K., Sethi, G. (2011-04-01). Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer. Cancer Letters 303 (1) : 9-20. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2010.10.025
Abstract: Identification of active constituents and their molecular targets from traditional medicine is an enormous opportunity for modern pharmacology. Celastrol is one such compound that was originally identified from traditional Chinese medicine (Thunder of God Vine) almost three decades ago and generally used for the treatment of inflammatory and auto-immune diseases. Celastrol has attracted great interest recently, especially for its potential anti-inflammatory and anti-cancer activities. The anti-inflammatory effects of this triterpene have been demonstrated in animal models of different inflammatory diseases, including arthritis, Alzheimer's disease, asthma, and systemic lupus erythematosus. This triterpene has also been found to inhibit the proliferation of a variety of tumor cells and suppress tumor initiation, promotion and metastasis in various cancer models in vivo. Celastrol's ability to modulate the expression of pro-inflammatory cytokines, MHC II, HO-1, iNOS, NF-κB, Notch-1, AKT/mTOR, CXCR4, TRAIL receptors DR4 and DR5, CHOP, JNK, VEGF, adhesion molecules, proteasome activity, topoisomerase II, potassium channels, and heat shock response has been reported. This review describes the various molecular targets of celastrol, cellular responses to celastrol, and animal studies with celastrol in cancer and other inflammatory disorders. © 2010 Elsevier Ireland Ltd.
Source Title: Cancer Letters
URI: http://scholarbank.nus.edu.sg/handle/10635/109796
ISSN: 03043835
DOI: 10.1016/j.canlet.2010.10.025
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

203
checked on May 29, 2020

WEB OF SCIENCETM
Citations

199
checked on May 21, 2020

Page view(s)

64
checked on May 23, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.